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Abstract
Craniopharyngiomas are common but complex paediatric
brain lesions that present interesting management
challenges. Quality of life is an important consideration
while choosing management options. In this review, we
have discussed the existing literature on various aspects of
quality of life in patients treated for craniopharyngioma,
assessed by variety of measurement tools.
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Introduction
Craniopharyngiomas are rare embryonic malformations of
sellar and parasellar areas of low histological malignancy,
thought to be derived from Rathke’s pouch epithelium. The
disease is treated with surgery and often adjuvant
treatment such as chemotherapy and radiotherapy. Due to
the location of pathology and its proximity to vital
structures, both the growth of CP as well as the treatment,
are associated with high risks for disturbing important
neurological and endocrine functions such as visual
impairment, stroke, obesity, pituitary insufficiency, etc.,
thus impairing the quality of life (QoL) in long-term
survivors. In this review, we have described how the CP and
its treatment may affect patients’ QoL despite good disease
control.
Review of literature
We have presented the literature, grouping the various
outcomes related to childhood onset craniopharyngioma
and its treatment into five major categories; obesity, visual
and neurological outcomes, endocrine imbalance,
psychological and psychosocial outcomes, and other
determinants of QoL. There is a large body of literature on
this topic, and we have only discussed a few publications
for each outcome. Some other notable references on the
topic are mentioned in the Table.
I. Obesity
Hypothalamic involvement (HI) either due to the CP, or its
treatment has significant effect on long term prognosis.
Childhood onset CPs with HI were associated with overall
reduced survival and increased Body Mass Index (BMI) at
diagnosis and follow up when compared with CPs without
HI. Children with hypothalamic lesion extending into the
nuclei of posterior hypothalamus, frequently develop
hypothalamic obesity (HO) syndrome which is
characterized by hyperphagia, diminished satiety,
decreased physical activity and consequential obesity. HO
risk assessment can be done using hypothalamic lesion
scoring (HLS) system which can predict the risk for
developing HO and may allow early initiation of
intervention strategies. After resection of the tumour,
patients with childhood onset CP had 50% increased rate
of obesity. Obese patients are at further increased risk of
developing subsequent atherosclerotic cardiovascular
diseases, metabolic syndromes and type 2 diabetes
mellitus (DM).1
II. Visual and neurological outcomes
Optic neuropathy may be observed in children with CP
despite few cases presenting with visual symptoms.2
Longstanding papilloedema, direct compression due to
tumour, radiotherapy and handling during surgery can all
injure the optic pathway, although, direct compression is
described as the major cause of visual loss.3 Pre-chiasmatic
tumours and critical pre-operative visual impairment are
risk factors for post-surgical visual disturbances. Surgery via
trans-sphenoidal route has shown better ophthalmological
outcomes, although it can be carried out in only a select
group of patients.4 Prevalence of persistent neurological
deficits is reported at around 8%, but may rise up to 36%
for larger tumours. Treatment related neurological deficits
include cranial nerve injury, stroke, and epilepsy.5
III. Endocrine imbalance
Around 40-80% children present with at least one
hormonal deficiency at the time of diagnosis. Diabetes
insipidus (DI) is found in 17-27% of patients.6,7 Tumour
extension and involvement of hypothalamic-pituitary axis
also affect the risks of post-operative endocrine
imbalance.5 Hoffman et al., assessed long term endocrine
status of 46 patients with childhood onset CP, and found
that all patients were using some form of hormone
replacement. Ninety three percent of these patients were
on 1-desamine-8-D-arginine vasopressin (DDAVP)
replacement, 89% cortisone, 83% thyroid, 30% sex
hormones and 20% were on growth hormone
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replacements.6 One of the early manifestation of paediatric
CP includes impaired growth, which often occurs years
before diagnosis. At the time of diagnosis, growth hormone
(GH) insufficiency has been recorded in 26-75% of CP
patients. On the other hand, GH deficiency was also present
in 70-92% of CP patients after treatment.7,8 The percentage
of post-operative DI is between 40-93% while transient
post-surgical DI develops in up to 80-100% of total cases.9
IV. Psychological and psychosocial wellbeing
Memmesheimer et al., predicted loss of concentration,
visual field defects, variable BMI and female sex as
strongest predictors for depression in patients treated for
CP. For anxiety, BMI, negative life incidents and sleepiness
were considered the main predictors.10 Sterkenburg et al.,
investigated psychosocial aspects such as education, job,
marriage, offspring, and having a driver’s license in 89 CP
patients and reported that only 2 of the 89 patients
surviving to adulthood had offspring (both without HI).11
V. Other determinants of QoL
Impaired hypothalamic-pituitary axis (HPA) in patients with
childhood onset CP predispose them to QoL consequences
that are more severe than adult onset CP, because they
haven’t established their career, professional lives and
family yet. Various studies report some clinical parameters
such as female sex, recurrent surgery, obesity, visual field
defects and radiotherapy to have adverse effects on QoL.
Majority of young adults with childhood onset CP have
difficulty developing relationships, separating from their
parents and may prefer continuing family support over an
independent life.10 Several studies suggest that the
neurobiological cause of the low QoL is involvement of
hypothalamus.7,11 The most common issues in paediatric
patients’ everyday life include incapability to control
emotions, low self-confidence, problems in pursuing
education and unease related to physical appearance.
Other hardships these patients face include decreased
mobility, less self-care, depression, anxiety, withdrawal and
somatic complaints such as pain.12 Neurocognitive deficits
such as reduced attention span, memory related problems,
sluggish cognitive speed and behavioural instability are
considered as precursors to weak academic performance.
Considering that intellectual stability has been described
in around 82% of patients, visual memory is till defective
despite normal visual spatial functioning.13 Mehren et al.,
suggested that childhood onset CP patients are at
increased risk for apathy, a condition associated with
reduced activities of daily living and poor treatment
outcomes due to lack of compliance. Apathetic symptoms
vary in individuals depending on the tumour extension and
involvement of motivational brain circuits.14 However,
interventions such as efficient psychosocial assistance and
self-care guidance may decrease the severity of disease.10
The importance of improved diagnostic facilities, new
techniques and early treatment has also been emphasized
as it may improve the chances of better QoL in these
patients.
Conclusion
Quality of life in craniopharyngioma patients is significantly
impaired even after surgical resection and besides a close
endocrine follow up, requires physical, psychological and
psychosocial rehabilitation.
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